nodes	percent_of_prediction	percent_of_DWPC	metapath
Beclomethasone—CYP3A5—Teniposide—lymphatic system cancer	0.542	0.675	CbGbCtD
Beclomethasone—CYP3A5—Vincristine—lymphatic system cancer	0.261	0.325	CbGbCtD
Beclomethasone—Cushing's syndrome—Carmustine—lymphatic system cancer	0.0225	0.114	CcSEcCtD
Beclomethasone—Skin striae—Bleomycin—lymphatic system cancer	0.0184	0.0932	CcSEcCtD
Beclomethasone—Ulcer—Bleomycin—lymphatic system cancer	0.00618	0.0313	CcSEcCtD
Beclomethasone—Wheezing—Bleomycin—lymphatic system cancer	0.00568	0.0288	CcSEcCtD
Beclomethasone—Bronchospasm—Teniposide—lymphatic system cancer	0.0056	0.0284	CcSEcCtD
Beclomethasone—Ulcer—Mitoxantrone—lymphatic system cancer	0.00502	0.0254	CcSEcCtD
Beclomethasone—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00439	0.0223	CcSEcCtD
Beclomethasone—Infection—Mechlorethamine—lymphatic system cancer	0.00436	0.0221	CcSEcCtD
Beclomethasone—Epistaxis—Fludarabine—lymphatic system cancer	0.00421	0.0213	CcSEcCtD
Beclomethasone—Sinusitis—Fludarabine—lymphatic system cancer	0.00419	0.0212	CcSEcCtD
Beclomethasone—Pharyngitis—Fludarabine—lymphatic system cancer	0.00398	0.0202	CcSEcCtD
Beclomethasone—Bronchospasm—Bleomycin—lymphatic system cancer	0.00361	0.0183	CcSEcCtD
Beclomethasone—Infection—Teniposide—lymphatic system cancer	0.00322	0.0163	CcSEcCtD
Beclomethasone—Cough—Fludarabine—lymphatic system cancer	0.00304	0.0154	CcSEcCtD
Beclomethasone—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00285	0.0144	CcSEcCtD
Beclomethasone—Infection—Fludarabine—lymphatic system cancer	0.00283	0.0143	CcSEcCtD
Beclomethasone—Rash—Mechlorethamine—lymphatic system cancer	0.00277	0.014	CcSEcCtD
Beclomethasone—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00277	0.014	CcSEcCtD
Beclomethasone—Nausea—Mechlorethamine—lymphatic system cancer	0.00261	0.0132	CcSEcCtD
Beclomethasone—Urticaria—Teniposide—lymphatic system cancer	0.00257	0.013	CcSEcCtD
Beclomethasone—Ulcer—Methotrexate—lymphatic system cancer	0.0025	0.0127	CcSEcCtD
Beclomethasone—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00249	0.0126	CcSEcCtD
Beclomethasone—Pain—Fludarabine—lymphatic system cancer	0.00243	0.0123	CcSEcCtD
Beclomethasone—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00237	0.012	CcSEcCtD
Beclomethasone—Cough—Bleomycin—lymphatic system cancer	0.00223	0.0113	CcSEcCtD
Beclomethasone—Back pain—Carmustine—lymphatic system cancer	0.00216	0.0109	CcSEcCtD
Beclomethasone—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00209	0.0106	CcSEcCtD
Beclomethasone—Infection—Bleomycin—lymphatic system cancer	0.00207	0.0105	CcSEcCtD
Beclomethasone—Back pain—Vincristine—lymphatic system cancer	0.00206	0.0104	CcSEcCtD
Beclomethasone—Rash—Teniposide—lymphatic system cancer	0.00204	0.0103	CcSEcCtD
Beclomethasone—Dermatitis—Teniposide—lymphatic system cancer	0.00204	0.0103	CcSEcCtD
Beclomethasone—Headache—Teniposide—lymphatic system cancer	0.00203	0.0103	CcSEcCtD
Beclomethasone—Back pain—Mitoxantrone—lymphatic system cancer	0.00201	0.0102	CcSEcCtD
Beclomethasone—Nausea—Teniposide—lymphatic system cancer	0.00192	0.00975	CcSEcCtD
Beclomethasone—Cough—Mitoxantrone—lymphatic system cancer	0.00181	0.00918	CcSEcCtD
Beclomethasone—Infection—Carmustine—lymphatic system cancer	0.00181	0.00917	CcSEcCtD
Beclomethasone—Rash—Fludarabine—lymphatic system cancer	0.00179	0.00909	CcSEcCtD
Beclomethasone—Dermatitis—Fludarabine—lymphatic system cancer	0.00179	0.00909	CcSEcCtD
Beclomethasone—Pain—Bleomycin—lymphatic system cancer	0.00178	0.00904	CcSEcCtD
Beclomethasone—Headache—Fludarabine—lymphatic system cancer	0.00178	0.00904	CcSEcCtD
Beclomethasone—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00174	0.00881	CcSEcCtD
Beclomethasone—Infection—Vincristine—lymphatic system cancer	0.00173	0.00876	CcSEcCtD
Beclomethasone—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00169	0.00858	CcSEcCtD
Beclomethasone—Nausea—Fludarabine—lymphatic system cancer	0.00169	0.00857	CcSEcCtD
Beclomethasone—Infection—Mitoxantrone—lymphatic system cancer	0.00168	0.00853	CcSEcCtD
Beclomethasone—Urticaria—Bleomycin—lymphatic system cancer	0.00166	0.0084	CcSEcCtD
Beclomethasone—Pain—Carmustine—lymphatic system cancer	0.00156	0.00789	CcSEcCtD
Beclomethasone—Pain—Vincristine—lymphatic system cancer	0.00149	0.00754	CcSEcCtD
Beclomethasone—Pain—Mitoxantrone—lymphatic system cancer	0.00145	0.00734	CcSEcCtD
Beclomethasone—Urticaria—Mitoxantrone—lymphatic system cancer	0.00134	0.00682	CcSEcCtD
Beclomethasone—Rash—Bleomycin—lymphatic system cancer	0.00132	0.00667	CcSEcCtD
Beclomethasone—Dermatitis—Bleomycin—lymphatic system cancer	0.00131	0.00666	CcSEcCtD
Beclomethasone—Epistaxis—Methotrexate—lymphatic system cancer	0.00125	0.00632	CcSEcCtD
Beclomethasone—Nausea—Bleomycin—lymphatic system cancer	0.00124	0.00628	CcSEcCtD
Beclomethasone—Dizziness—Carmustine—lymphatic system cancer	0.0012	0.0061	CcSEcCtD
Beclomethasone—Pharyngitis—Methotrexate—lymphatic system cancer	0.00118	0.00597	CcSEcCtD
Beclomethasone—Dizziness—Vincristine—lymphatic system cancer	0.00115	0.00583	CcSEcCtD
Beclomethasone—Rash—Carmustine—lymphatic system cancer	0.00115	0.00582	CcSEcCtD
Beclomethasone—Dermatitis—Carmustine—lymphatic system cancer	0.00115	0.00582	CcSEcCtD
Beclomethasone—Headache—Carmustine—lymphatic system cancer	0.00114	0.00578	CcSEcCtD
Beclomethasone—Rash—Vincristine—lymphatic system cancer	0.0011	0.00556	CcSEcCtD
Beclomethasone—Dermatitis—Vincristine—lymphatic system cancer	0.0011	0.00555	CcSEcCtD
Beclomethasone—Headache—Vincristine—lymphatic system cancer	0.00109	0.00552	CcSEcCtD
Beclomethasone—Nausea—Carmustine—lymphatic system cancer	0.00108	0.00548	CcSEcCtD
Beclomethasone—Rash—Mitoxantrone—lymphatic system cancer	0.00107	0.00541	CcSEcCtD
Beclomethasone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00107	0.00541	CcSEcCtD
Beclomethasone—Headache—Mitoxantrone—lymphatic system cancer	0.00106	0.00538	CcSEcCtD
Beclomethasone—Nausea—Vincristine—lymphatic system cancer	0.00103	0.00523	CcSEcCtD
Beclomethasone—Nausea—Mitoxantrone—lymphatic system cancer	0.00101	0.0051	CcSEcCtD
Beclomethasone—Back pain—Methotrexate—lymphatic system cancer	0.001	0.00507	CcSEcCtD
Beclomethasone—Cough—Methotrexate—lymphatic system cancer	0.000902	0.00457	CcSEcCtD
Beclomethasone—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000844	0.00428	CcSEcCtD
Beclomethasone—Infection—Methotrexate—lymphatic system cancer	0.000838	0.00425	CcSEcCtD
Beclomethasone—Pain—Methotrexate—lymphatic system cancer	0.000721	0.00366	CcSEcCtD
Beclomethasone—Urticaria—Methotrexate—lymphatic system cancer	0.00067	0.0034	CcSEcCtD
Beclomethasone—Dizziness—Methotrexate—lymphatic system cancer	0.000558	0.00283	CcSEcCtD
Beclomethasone—Rash—Methotrexate—lymphatic system cancer	0.000532	0.0027	CcSEcCtD
Beclomethasone—Dermatitis—Methotrexate—lymphatic system cancer	0.000531	0.00269	CcSEcCtD
Beclomethasone—Headache—Methotrexate—lymphatic system cancer	0.000528	0.00268	CcSEcCtD
Beclomethasone—Nausea—Methotrexate—lymphatic system cancer	0.000501	0.00254	CcSEcCtD
